Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative bioethics in bipolar and epilepsy research.

Kenneth R Kaufman1

  • 1UMDNJ-Robert Wood Johnson Medical School, 125 Paterson Street, Suite #2200, New Brunswick, NJ 08901, USA. kaufmakr@umdnj.edu

Seizure
|March 13, 2002
PubMed
Summary

Anticonvulsant drug (AED) trials for bipolar disorder need enhanced safety protocols. Bipolar depression carries suicide risks, necessitating add-on studies similar to epilepsy research to protect patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Applying cultural psychiatry to non-pharmacological interventions.

BJPsych open·2026
Same author

University student mental health research: look back to move forward.

BJPsych open·2026
Same author

Topical editorials, papers and commentaries: next 10 years.

BJPsych open·2026
Same author

Why followership matters in psychiatry: rebalancing our obsession with leadership.

BJPsych open·2026
Same author

Enhancing the quality of systematic reviews and meta-analyses.

BJPsych open·2025
Same author

Solution-focused approaches to improving the careers of women academics in psychiatry: UK viewpoint.

BJPsych open·2025

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Trial Design

Background:

  • Anticonvulsant drugs (AEDs) are evaluated for bipolar disorder using double-blind, placebo-controlled, randomized clinical trials (RCTs) as mandated by the FDA.
  • Current trial designs may underestimate risks such as suicide, long-term morbidity, and rapid regression during placebo or dose-ranging phases in bipolar depression.
  • Ethical considerations regarding patient safety in FDA-required protocols for bipolar disorder warrant re-evaluation.

Purpose of the Study:

  • To critically assess the ethical implications and safety of current FDA-required clinical trial designs for anticonvulsant drugs in bipolar disorder.
  • To advocate for modified trial designs, specifically add-on studies, to mitigate risks inherent in bipolar disorder research.
  • To draw parallels between safety protocols in epilepsy and bipolar disorder research, considering the significant risks in each population.
Keywords:
Biomedical and Behavioral Research

Related Experiment Videos

Main Methods:

  • A comparative analysis of research designs employed in epilepsy and bipolar disorder clinical trials.
  • A comprehensive literature review focusing on the methodologies and ethical considerations of randomized clinical trials (RCTs) for AEDs in psychiatric and neurological conditions.

Main Results:

  • The FDA mandates RCTs for psychiatric drug approvals, while epilepsy drug approvals initially focus on add-on efficacy.
  • Epilepsy research utilizes phased approaches, including cross-over studies and placebo trials, only after initial add-on efficacy is established, prioritizing seizure risk minimization.
  • Current psychiatric trial designs for AEDs in bipolar disorder may not adequately address the unique risks of suicide and long-term morbidity.

Conclusions:

  • Bipolar disorder research, like epilepsy research, should adopt initial add-on studies for new AEDs to ensure patient safety during the placebo phase.
  • Implementing add-on study designs in bipolar disorder research would significantly increase patient safety, despite potentially requiring larger patient cohorts for statistical efficacy.
  • Enhanced ethical considerations, including increased patient contact and co-signed informed consent with a significant other, are crucial for bipolar disorder research safety.